𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Down's syndrome and maternal smoking in early pregnancy

✍ Scribed by Karin Källén


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
31 KB
Volume
14
Category
Article
ISSN
0741-0395

No coin nor oath required. For personal study only.

✦ Synopsis


Several previous studies have suggested that maternal smoking is associated with a decreased incidence of trisomy 21. By using the Swedish health registries, 1,321 infants with Down's syndrome (DS) were selected among 1,117,021 infants born in 1983-1993 with known smoking exposure in early pregnancy. No association between maternal smoking and all cases of DS was found [age-adjusted odds ratio (OR) for maternal smoking: 0.98; 95% confidence interval (CI): 0.86-1.11], but heterogeneity over strata existed. A slightly decreased OR (0.91; 95% CI: 0.72-1.15) for any maternal smoking was indicated among primiparas, but among multiparas, no effect of smoking on the incidence of DS could be detected (OR: 1.01; 95% CI: 0.87-1.17). The difference between the OR for smoking ≥10 cigarettes per day among primiparas (OR: 0.59; 95% CI: 0.38-0.90) and multiparas (OR: 1.06; 95% CI: 0.86-1.31) was statistically significant.

If not due to statistical fluctuation, the findings indicate that no direct effect of smoking on DS risk exists but the association observed in primiparas is due to covarying factors.


📜 SIMILAR VOLUMES


Maternal serum S100 protein in normal an
✍ H. D. Abraha; P. L. Noble; K. H. Nicolaides; R. A. Sherwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

Protein S100 is a low molecular weight (10-12 kD) calcium-binding protein the beta subunit of which is coded for at the 22.2-22.3 region of the long arm of chromosome 21. This region has also been shown to be responsible for the phenotypic expression of Down syndrome. Previous studies demonstrated i

Maternal urine hyperglycosylated hCG in
✍ H. S. Cuckle; S. Shahabi; I. K. Sehmi; R. Jones; L. A. Cole 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

Stored maternal urine samples were used to determine the distribution of hyperglycosylated human chorionic gonadotrophin (H-hCG) levels in pregnancies with Down syndrome. A total of 349 samples from singleton pregnancies, including 45 with Down syndrome, were tested at 10-19 weeks' gestation. Urinar

MATERNAL SERUM SCREENING FOR FETAL DOWN
✍ L. S. M. RIBBERT; L. H. KORNMAN; B. T. H. M. DE WOLF; A. H. M. SIMONS; C. A. M. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB 👁 2 views

To assess the influence of in vitro fertilization (IVF) on maternal serum human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP), the maternal serum hCG and AFP values were studied in 67 IVF pregnancies and compared with the results of a control group of 4732 spontaneously conceiving patien

Maternal serum activin A and follistatin
✍ H. S. Cuckle; I. Sehmi; R. Jones; L. W. Evans 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

Inhibin A is now an established second-trimester maternal serum marker of Down syndrome. Since activin A has a common -subunit to inhibin A we evaluated this substance and its binding protein, follistatin, as potential markers. We studied 30 affected and 199 unaffected pregnancies at 13-16 weeks' ge